Symbol
CADL on Nasdaq
Investment type
Equity / Common stock, par value $0.0001 per share
Latest Disclosed Ownership
0 shares
Security Ownership
0%

Northpond Ventures, LP ownership in Candel Therapeutics, Inc. Common stock, par value $0.0001 per share (CADL)

2025-02-14 - Northpond Ventures, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Candel Therapeutics, Inc. Common stock, par value $0.0001 per share (CADL). This represents 0% percent ownership of the company.